SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
NCT05770687 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-01-03
Summary
Prospective trials performed on type 2 diabetes patients without established cardiovascular disease has shown that SGLT2 inhibitors reduce cardiovascular risk. No studies have yet examined the occurrence of cardiovascular disease in patients with acute myocardial infarction.
The investigators designed the current study to evaluate the most ideal oral hypoglycemic agent in type 2 diabetes patients undergoing percutaneous coronary intervention for acute myocardial infarction. The investigators hypothesize that the use of SGLT-2 inhibitors will reduce cardiovascular events and modify left ventricular remodeling after myocardial infarctions.
Conditions
- Myocardial Infarction
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
SGLT2 inhibitor
Patients started on SGLT2 inhibitors after PCI for AMI
Sponsors & Collaborators
-
Seoul St. Mary's Hospital
collaborator OTHER -
Uijeongbu St. Mary Hospital
collaborator OTHER -
Incheon St.Mary's Hospital
collaborator OTHER -
Daejeon St. Mary's hospital
collaborator OTHER -
Bucheon St. Mary's Hospital
collaborator OTHER -
St Vincent's Hospital
collaborator OTHER -
Yeouido St. Mary's Hospital
collaborator OTHER -
Sejong General Hospital
collaborator OTHER -
Pusan National University Hospital
collaborator OTHER -
Andong Hospital
collaborator UNKNOWN -
Chungnam National University Hospital
collaborator OTHER -
St. Carollo General Hospital
collaborator UNKNOWN -
Pusan National University Yangsan Hospital
collaborator OTHER -
Kyungpook National University Hospital
collaborator OTHER -
Jeju National University Hospital
collaborator OTHER -
Korea University Anam Hospital
collaborator OTHER -
Inje University
collaborator OTHER -
Kiyuk Chang
lead OTHER
Principal Investigators
-
Kiyuk Chang, MD, PhD · Seoul St. Mary's Hospital
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Effect of SGLT2 Inhibitors on Heart Rate Variability and BDNF Levels in Patients With Type 2 Diabetes
NCT05164523 ·Status: COMPLETED
-
Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients
NCT00455988 ·Status: UNKNOWN
-
Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)
NCT04304261 ·Status: COMPLETED ·Phase: PHASE3
-
SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes
NCT05256706 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129 ·Status: RECRUITING
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NCT05369065 ·Status: RECRUITING ·Phase: PHASE1
-
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
NCT01056367 ·Status: COMPLETED
-
Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care
NCT01049737 ·Status: COMPLETED
-
Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes
NCT01505036 ·Status: COMPLETED ·Phase: NA
-
The Effects of SGLTi on Diabetic Cardiomyopathy
NCT04200586 ·Status: UNKNOWN ·Phase: PHASE4
-
The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction
NCT02250989 ·Status: UNKNOWN
-
Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCI
NCT05134129 ·Status: UNKNOWN
-
An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes
NCT03811288 ·Status: COMPLETED
-
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
NCT00021944 ·Status: COMPLETED
-
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
NCT05040087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Self-Care for Older People With Diabetes Mellitus
NCT03890991 ·Status: UNKNOWN ·Phase: NA
-
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases
NCT04983277 ·Status: NOT_YET_RECRUITING
-
Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications
NCT05787990 ·Status: UNKNOWN
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea
NCT01154244 ·Status: COMPLETED
-
Ischemic Preconditioning and Type 2 Diabetes
NCT03598855 ·Status: COMPLETED ·Phase: NA
-
Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
NCT03558867 ·Status: COMPLETED ·Phase: NA